The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)
Clinical trial NCT07065968 · RECRUITING
Trial details
- NCT number
- NCT07065968
- Sponsor
- Peking University People's Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-19
- Primary completion
- 2027-09-10
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.